Erschienen in:
05.08.2020 | Concise Research Report
Management of Elevated Troponin I Levels in Adult Medical Inpatients
verfasst von:
Tyler W. Wark, M.D., William R. Lang, M.D., Kate E. Cahill, M.D., Rebekah L. Gardner, M.D.
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 10/2021
Einloggen, um Zugang zu erhalten
Excerpt
The classification of elevated cardiac troponin levels has expanded with the advent of high sensitivity troponin assays over the last decade.
1, 2 A type 2 myocardial infarction (T2MI) is defined by an ischemic event due to myocardial oxygen supply-demand mismatch. Clinically, T2MI events are accompanied by ischemic findings, including chest pain and electrocardiogram changes. In contrast, patients with myocardial injury do not display evidence of ischemia. Despite their descriptive differences, both conditions are associated with short- and long-term increases in morbidity and mortality.
2, 3 The timing and value of preventive medical therapy and secondary risk stratification remain largely undefined for these entities.
4 The aim of this study was to investigate how patients with elevated troponin levels are managed in the hospital, with a focus on titration of cardiac medications, cardiac testing, and recommendations for outpatient evaluation. …